Investors target Chinese cancer drugs

Drug developers such as I-Mab are trying to lead the market and secure future cash flow with their technological progress.

The search for anti-cancer drugs has strong support from the Chinese government which has spurred investors to pour money into the sector. What's hot this year seems to be immuno-oncology and the related field of precision medicine.

¬ Haymarket Media Limited. All rights reserved.

Sign In to Your Account To Access Exclusive FinanceAsia Content!

Please sign in to your subscription to unlock full access to our premium FA resources.

Free Registration & 7-Day Trial
Register now to enjoy a 7-day free trial - no registration fees required. Click the link to get started.

Note: This free trial is a one-time offer.

Questions?
If you have any enquiries or would like a quote for a team or company licence, please contact us at [email protected]. Our subscription team will be happy to assist you.

Share our publication on social media
Share our publication on social media